Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Cosmos Health Inc. (COSM)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 · Dec 31 | 2013 · Jul 31 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M | $55.4M | $39.7M | $37.1M | $30.0M | $6.8M | $533,802 | $7.6M | $902,369 | — | — | — | — |
| Gross profit | $7.9M | $4.3M | $4.3M | $6.0M | $8.3M | $8.1M | $3.7M | $2.4M | $2.0M | $601,040 | $48,993 | $7.6M | — | — | — | — | — |
| Research & development | $519,363 | $533,293 | $164,859 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $24.6M | $19.9M | $26.2M | $13.4M | $12.9M | $5.3M | $3.9M | $3.6M | $6.8M | $803,547 | $491,452 | $523,305 | — | — | — | — | — |
| Operating income | −$16.7M | −$15.5M | −$21.8M | −$7.5M | −$4.5M | $2.7M | −$255,809 | −$1.2M | −$4.9M | −$202,507 | −$442,459 | $7.1M | $288,712 | −$344,543 | −$330,589 | −$169,245 | — |
| EBITDAderived | −$15.3M | −$14.3M | −$21.2M | −$7.4M | −$4.2M | $3.1M | $138,819 | −$1.2M | −$4.8M | −$193,059 | — | — | — | — | — | — | — |
| Net income | −$19.1M | −$16.2M | −$18.5M | −$13.8M | −$8.0M | $820,786 | −$3.3M | −$9.1M | −$6.2M | −$601,002 | −$6.7M | $6.0M | $246,592 | −$344,543 | −$330,589 | −$169,245 | −$3.8M |
| Basic EPSper diluted share | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 | $0.06 | -$0.25 | -$0.68 | -$0.49 | $0.00 | -$0.05 | $0.05 | $0.00 | -$0.01 | -$0.01 | -$0.01 | — |
| Diluted EPSper diluted share | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 | $0.06 | -$0.25 | -$0.68 | -$0.49 | $80,741.00 | -$0.05 | $0.05 | $0.00 | -$0.01 | -$0.01 | -$0.01 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026Form 4 | Terzis GeorgiosChief Financial Officer | BuyCommon Stock, par value $.001 | 168.1K | $0.25 | $42.0K | 2.24M |
| Jun 11, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 218.4K | $0.21 | $45.9K | 13.48M |
| Jun 10, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 701.4K | $0.23 | $161.3K | 13.26M |
| Feb 12, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 388.5K | $0.37 | $143.8K | 8.86M |
| Feb 11, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 291.3K | $0.41 | $119.4K | 8.47M |